iVEDiX, a premier business intelligence company that specializes in mobile solutions, is announcing an international partnership with TechAccess. According to iVEDiX, this partnership is focused on providing top-quality mobile analytics solutions to the region, specifically by utilization of the miVEDiX mobile analytics platform.
Utilization of TA’s extensive distribution and partner network gives iVEDiX international reach. In turn, miVEDiX, iVEDiX’s flagship mobile analytics platform, provides TA with a mobile-centric product in a region that is rapidly embracing big data and mobility in the tech and IT sectors.
Brian Annechino, Director of Sales and Partnerships, notes that this deal “Ignites the iVEDiX channel partner strategy. By partnering with TechAccess, we can storm the market with a proven support and delivery system that puts miVEDiX into the hands of users so they can start utilizing their organization’s data in a way that drives insights. TA have a terrific track record when it comes to distribution reach, support structures, and experience fulfilling customer needs. So this is a great opportunity for both organizations.”
Chris Cornelius, Senior Vice President of Sales & Support for TA shared his enthusiasm for this new venture and added, “This is our first step into distribution of applications and in doing so we have embarked on an internal proof of concept by installing miVEDIX at TA as a front-end to our internal BI system. Having this BI at our fingertips enriches our conversations with our partners which translate into more meaningful relationships. TA is now going to enable selected reselling partners to take miVEDIX to market and enable the vast amount of customers who need mobile BI at their fingertips.”
In addition to providing a streamlined distribution process, TA provides a host of value-added services to the miVEDiX rollout: a multi-million dollar solution center, dedicated sales and pre-sales support, and marketing and business development support. This is the largest partnership yet for the New York-based company, and marks the first distribution of miVEDiX on an international scale.